SlideShare a Scribd company logo
1 Diagnostic Cytopathology of  Serous Effusions   Session II   ( 8.45-9.30 ) To view this session on web copy-paste the following URL into your browser:   http://www.slideshare.net/vshidham/02-presentations-ii-vs-14-4-mb-3-30-08   Vinod B. Shidham , MD, FRCPath, FIAC  Professor Executive editor & coeditor-in-chief, CytoJournal ( www.cytojournal.com ) Department of Pathology  Medical College of Wisconsin  9200 W Wisconsin Av,  Milwaukee, WI 53226, USA  [email_address]   2008 Wisconsin Society of Cytology SPRING MEETING, 40TH ANNIVERSARY Holiday Inn – Riverwalk, Neenah, WI Saturday, April 19, 2008 (7.30 to 3.30)
2 Outline Session I  (40 minutes): Anatomy, histology, cytology, and effusions Collection, transportation, and processing of effusion fluids Factors leading to potential diagnostic pitfalls Approach to diagnostic cytopathology of effusions The panorama of different face of mesothelial cells Session II  (45 minutes): Benign conditions with/without specific cellular patterns Mesothelioma Metastatic carcinoma Metastatic sarcoma and melanoma Hematolymphoid disorders (Lymphomas and leukemias) Session III  (45 minutes): Evaluation of unknown primary sites of origin- Where do they come from?  Immunocytochemistry of effusion fluids:  SCIP (Subtractive Coordinate  Immunoreactivity Pattern) approach Flow cytometry, molecular techniques, and other special techniques Session IV  (45 minutes): Diagnostic cytopathology of peritoneal washings Diagnostic pitfalls in cytopathology of serous cavity fluids Study cases
2 Outline Session I (40 minutes): Anatomy, histology, cytology, and effusions Collection, transportation, and processing Factors leading to potential diagnostic pitfalls Approach to diagnostic cytopathology of effusions The panorama of different face of mesothelial cells Session II  (45 minutes): Benign conditions with/without specific cellular patterns Mesothelioma Metastatic carcinoma Metastatic sarcoma and melanoma Hematolymphoid disorders (Lymphomas and leukemias) Session III (45 minutes): Evaluation of unknown primary sites of origin- Where do they come from?  Immunocytochemistry of effusion fluids:  SCIP (Subtractive Coordinate  Immunoreactivity Pattern) approach Flow cytometry, molecular techniques, and other special techniques Session IV (45 minutes): Diagnostic cytopathology of peritoneal washings Diagnostic pitfalls in cytopathology of serous cavity fluids Study cases
In  adults   most  of the pleural, peritoneal, and pericardial effusions are related to  benign conditions  like:  Congestive heart failure  Cirrhosis of the liver Pericarditis.  3
4 Benign conditions with/without specific cellular patterns Session II May mimic carcinoma  Extremely reactive mesothelial cells may exhibit atypia overlapping with malignancy  Diagnose of malignancy with extreme caution.  Immunophenotyping with SCIP approach objectively decide nature of atypical cells.   Liver Cirrhosis with activity Uremia Acute Pancreatitis Pulmonary embolism and Infarction With  characteristic features Systemic Lupus Erythematosus ( SLE) Rheumatoid Effusions Other less common causes of reactive effusions Fistulous tract associated effusions Endometriosis Asbestos exposure associated effusions Talc associated effusions.
Mesothelial cells  vs  adenocarcinoma   cells Benign conditions with/without specific cellular patterns  (continued) 5 Cytologic Features  Mesothelial Cells  Adenocarcinoma Cell Types  Single cell population (spectrum of mesothelial cells)  Second population (mesothelial cells and nonmesothelial-noninflammatory cells) Borders of cell groups Hobnail with cytoplasmic   Intercellular windows- Present Smooth  community borders of  nuclei Intercellular windows- May be present Cell in cell pattern Present  Rare Vauolated cells  (Signet ring appearance) Absence of mucin  in cells Nuclear borders not distorted “ Mucin droplet” present Vacuole distorts cell nucleus Cytoplasm Ecto- and endoplasm Usually  homogenous-random Cytoplasmic Blebs Present Absent Immunohistochemistry  Mesothelial markers-  Positive Epithelial markers-  Positive Microvilli (EM) Long, slender, bushy Short, stubby, sparse
Benign conditions with/without specific cellular patterns  (continued) Reactive mesothelial cells in clusters  (ascitic fluid). Mixed with chronic inflammatory cells within the groups and between the mesothelial cells in the background.  [Papanicolaou stained ThinPrep preparation (100x Zoomed)]. 6
Benign conditions with/without specific cellular patterns  (continued) Reactive mesothelial cells in clusters  mixed with chronic inflammatory cells, mostly mature lymphocytes (ascitic fluid). This consult case was initially misinterpreted as positive for malignant cells. Extensive search for primary was negative. [Papanicolaou stained ThinPrep preparation (100x Zoomed)]. 7
Benign conditions with/without specific cellular patterns  (continued) a b c RM-b RM-c F2 F1 F2 F1 Degenerative vacuoles in reactive mesothelial cells  (ascitic fluid).  8
Benign conditions with/without specific cellular patterns  (continued) A  thin rim between nuclear border and cell border  (1) is seen in mesothelial cells. In comparison, the nuclear border touches the cell border of adenoca cells without a significant cytoplasmic rim (2).  [Papanicolaou stained SurePath TM  Preparation (b,c,e,f, 100XZoomed)]. Mesothelial cells  (a,b,&c)   versus  adenocarcinoma cells  (d,e,&f)   with   eccentric nuclei .   9 2 2 2 f e d Adenocarcinoma 1 1 1 a c b Mesothelial
10 Peritoneal: Lymphocytic Peritoneal Effusions Cirrhosis Tuberculosis Eosinophilic Peritoneal Effusions Neutrophilic Peritoneal Effusions Spontaneous bacterial peritonitis Extramedullary hematopoiesis /  chronic idiopathic myelofibrosis Benign conditions with/without specific cellular patterns  (continued) Reactive inflammatory cells in effusion fluids Pleural: Reactive lymphocytic pleural effusions Tuberculosis Eosinophilic Pleural Effusions  Neutrophilic Pleural Effusions Pulmonary embolism Parapneumonic effusions Histiocytic Pleural Effusions Rheumatoid arthritis Nodular histiocytic hyperplasia  Pericardial Lymphocytic Pericardial effusions Viral pericarditis Eosinophilic Pericardial Effusions Neutrophilic Pericardial Effusions Infectious pericarditis Systemic lupus erythematosus
Benign conditions with/without specific cellular patterns  (continued) Session II Most frequently  exudative Usually  pleural , less frequently  pericardial . Cytology:   Predominance of inflammatory cells (neutrophils, rarely eosinophils or lymphocytes).  Most characteristic features is the presence of  LE cells - Inflammatory cells (usually a neutrophil, but could be a macrophage)  Containing a  homogenous hematoxylin body .  The number of LE cells noted in effusion sample can vary.  Characteristic but not pathognomonic ,  other conditions including  drug  (e.g. procainamide, hydralazine, and  isoniazid) associated with an SLE-like syndrome   may show LE cells.  Not consistent association.  Systemic Lupus Erythematosus (SLE) 11
Benign conditions with/without specific cellular patterns  (continued) Session II Systemic Lupus Erythematosus (SLE) LE cells 12 Pleural effusion ,   Diff Quik stain, 40X Pleural effusion ,   Papanicolaou stain, 40X
Benign conditions with/without specific cellular patterns  (continued) Session II Rheumatoid effusions Uncommon but  known complication  of rheumatoid arthritis.  May be  concurrent , or occur  prior to  manifestations of joint disease.  Eexudative, more frequently in  males  than females.  Fluids have  reduced glucose  levels.  Cytology  Characteristic:  Many  degenerated cells ,  necrotic debris ,  atypical spindled cells  resembling spindled squamous cells,  histiocytes , and  round multinucleated giant cells  with many  lymphoplasmacytic cells . Mesothelial cells- absent or may be rare.  Presence of necrosis in an effusion specimen is almost characteristic for a rheumatoid nodule. Spindled cells with varying degrees of degeneration and frequent pyknosis, may raise the  differential diagnosis with squamous cell carcinoma .  Non-specific:  The characteristic features- not consistent.  May only show  general reactive pattern - increased neutrophils, lymphocytes and mononuclear cells with reactive mesothelial cells.  13
Benign conditions with/without specific cellular patterns  (continued) Session II Rheumatoid effusions Lung nodule and pleural effusion.  Multinucleated giant cells with many chronic inflammatory cells. Degenerating as well necrotic cells characteristic of rheumatoid effusion are in the background.  (Papanicolaou stain, 40X) 14
Cells in effusion fluid Mesothelial cells Neoplastic-   ♦ Quantity-  Many cells  ♦ Quality-  Many large groups Mesothelioma Non-mesothelial cells Reactive- Usually single cells without large 3-D groups Hematopoietic cells (Non-cohesive cells) Neoplastic - (2nd foreign population) ¶ Carcinoma (Cohesive cells) Sarcoma (Spindle cells may be present. Known history of  sarcoma is usually crucial for proper interpretation)  Melanoma (Non-cohesive cells) Neoplastic-  Lymphoma Reactive- Inflammatory cells ¶ Metastatic cancer cells may be the  predominant cells  without being seen as a ‘second population’. They may be present as  scattered solitary cells  with cytomorphology overlapping with floridly reactive mesothelial cells. If indicated, i mmunocytochemistry  would facilitate confirmation of these cells as non-mesothelial.  1 3 2 4 7 6 5 6b 6a 8 Algorithm for evaluation of a ‘second foreign population’ . 15
Mesothelioma Diagnostic problems in cytological interpretation  Cytological features of mesothelioma Rare variants- Clear cell Deciduoid Lymphohistiocytoid  Signet-ring cell  Small cell Special stains in mesothelioma 16
Mesothelioma  (continued) Significant overlap between benign and malignant mesothelial cells, and between mesothelioma and adenocarcinoma cells.  Important clues  are  quantitative  and  qualitative Quantity-   Hypercellular  specimns with  numerous mesothelial cells Ouality-   Large groups  of  three dimensional  mesothelial cells  Most of these features are evaluated better on  Romanowski stained  preparations. Diagnostic problems   Large aggregates of reactive mesothelial cells- may be misinterpreted with false positive diagnoses. 17
Mesothelioma  (continued) A single malignant mesothelial cell population  Multinucleation  Articulation between mesothelial cells  (intercellular windows) Cell-in-cell arrangements Cytoplasmic vacuoles Peripheral blebs Cluster of atypical cells with knobby outlines  (scalloped borders) Variable nuclear enlargement with prominent nucleoli  Cytoplasmic metachromasia Cytological features of mesothelioma 18
Mesothelioma  (continued) Atypical mitoses  may be seen rarely. Background extracellular stromal  hyaluronic acid -  Metachromatic  appearance on  Romanowski stains  and  Fluffy pale green/blue  appearance on the  Papanicolaou stain . Cytological features of mesothelioma Mesothelial cells  (both reactive and neoplastic)-  Distinct two-zone  appearance with an  inner dense ring  fading into  an  outer, delicate, lacy  area.  Distinguishes mesothelial from  adenocarcinoma cells ,  with  diffuse pale cytoplasm with random pattern . General cytological nuclear features of malignancy apply to mesothelioma-   Irregular, pleomorphic and enlarged nuclei, prominent nucleoli (including  macronucleoli), bi- and multinucleation.  However,  the features are somewhat  subtle  and need to be carefully searched.  19
Mesothelioma  (continued) Mesothelioma - clusters of cells with irregular,  knobby outlines-  sometimes resemble  papillary architecture .  Acinar formation  (a feature of  adenocarcinoma )  rare in mesotheliomas .  Intercellular windows  may appear like acini.. Cell engulfment  (cell-in-cell) is a common  in mesotheliomas .  Benign effusions-  relatively less cellular, with smaller cell groups, mostly two-dimensional. The individual cells may show variable atypia.  Adenocarcinoma  cell groups-  three-dimensional, complex, with a smooth contour (the so-called  “ community border ” ).  Cytological features of mesothelioma Spindle cells  rarely exfoliate in effusion fluids- they may appear polyhedral owing to the  surface tension phenomenon .  Scattered  atypical spindle cells - suspicious for  mesothelioma .  20
Mesothelioma  (continued) Cytological features of mesothelioma Mesothelial cell with two zone cytoplasm (white arrow) and fuzzy microvilli (black arrow).  Autocyte Prep. Pap stain 40x. 21
Mesothelioma  (continued) Cytological features of mesothelioma Loosely cohesive three-dimensional  groups of mesothelioma cells with knobby outline.  A multinucleate atypical mesothelial cell is seen at the periphery of the group (arrow).  Thinprep. Pap stain 40x. 22
Mesothelioma  (continued) Cytological features of mesothelioma Mesothelial cell with prominent microvilli (white arrow).  Autocyte Prep. Pap stain. 60x. 23
Mesothelioma  (continued) Cytological features of mesothelioma Malignant epithelioid mesothelioma  (pleural fluid). Mesothelioma cells show numerous large three dimensional groups of cells. The individual mesothelioma cells hardly show any variation from reactive mesothelial cells without remarkable features of malignancy. The mesothelioma cells like reactive mesothelial cells show two zone staining (red arrow 1) with peripheral vacuolation (blue arrow 2).  [a-h, Papanicolaou stained ThinPrep preparation (a,b, 20X; c, 100X; d-h, 100XZoomed)]. 24 1 2 a b c e f g h d
Mesothelioma  (continued) Cytological features of mesothelioma Cell block from a case of mesothelioma showing hypercellular atypical mesothelial cell groups. Extracellular mucinous material is present in the background (white arrow). H&E. 40X. 25
Mesothelioma  (continued) Cytological features of mesothelioma Loosely cohesive small group of spindled mesothelial cells in a case of biphasic mesothelioma. Arrow marks an atypical spindled nucleus.  Autocyte Prep. Pap stain. 40x. 26
Mesothelioma  (continued) Peritoneal fluid, Deciduoid mesothelioma . Dyscohesive scattered single atypical enlarged cells  Pap stain 10X.  [Courtesy  Dr. Bernard Naylor]. Cytological features of mesothelioma 27
Mesothelioma  (continued) Peritoneal fluid,  Deciduoid mesothelioma.   Enlarged malignant cells with a binucleate form, and glassy cytoplasm. Nuclei are vesicular with prominent nucleoli. Scattered smaller atypical mesothelial cells are present in the background.  Pap stain 40X   [Courtesy Dr. Bernard Naylor]. Cytological features of mesothelioma 28
Mesothelioma  (continued) Special stains in mesothelioma  Mesothelial cells produce  hyaluronic acid - an acidic mucin. Also seen in the background of effusion smears.  Adenocarcinoma cells  produce  neutral mucin .  Mesotheliomas-  positive for  acidic mucin stains  such as  Alcian Blue .  The staining disappears with  hyaluronidase pre-digestion .  Adenocarcinomas-   epithelial (neutral) mucin-   Positive with  mucicarmine  and  PAS  (diastase resistant)-  PAS positive glycogen in mesothelial cells is hydrolyzed by diastase digestion .  A positive stain for an epithelial mucin- is useful for a diagnosis of adenocarcinoma,  but a negative result does not exclude it. 29
Cells in effusion fluid Mesothelial cells Neoplastic-   ♦ Quantity-  Many cells  ♦ Quality-  Many large groups Mesothelioma Non-mesothelial cells Reactive- Usually single cells without large 3-D groups Hematopoietic cells (Non-cohesive cells) Neoplastic - (2nd foreign population) ¶ Carcinoma (Cohesive cells) Sarcoma (Spindle cells may be present. Known history of  sarcoma is usually crucial for proper interpretation)  Melanoma (Non-cohesive cells) Neoplastic-  Lymphoma Reactive- Inflammatory cells ¶ Metastatic cancer cells may be the  predominant cells  without being seen as a ‘second population’. They may be present as  scattered solitary cells  with cytomorphology overlapping with floridly reactive mesothelial cells. If indicated, i mmunocytochemistry  would facilitate confirmation of these cells as non-mesothelial.  1 3 2 4 7 6 5 6b 6a 8 Algorithm for evaluation of a ‘second foreign population’ . 30
Metastatic carcinoma Common sources of  primary neoplasms causing malignant effusions. Any neoplasm, including rare examples of central nervous system tumor, may involve serous cavity and manifest as malignant effusion.  Metastatic adenocarcinoma  is, by far, the  most common  cause of malignant effusions.  31
Metastatic carcinoma  (continued) Clinical details may be important for cytologic interpretation of effusions.  However, depending on the clinical scenario and cytological picture, the clinical history may be misleading, especially with beginners.  Some effusions may develop without any history of cancer and may present a diagnostic challenge.  Clinical history 32
Clinical history  (continued) The  clinical history  can play a critical role in ensuring  proper triaging  and  processing  of effusion specimens; therefore, to facilitate appropriate processing of effusions, the clinical history should be provided in all the requisitions. This could  avoid  suboptimal cytopathologic interpretations.  Metastatic carcinoma  (continued) 33
If the initial findings are  equivocal  for cancer cells, it is prudent to be  extra-cautious  by recommending  repeat  cytologic evaluation on a new specimen.  If the initial effusion is caused by cancer, it usually  re-accumulates  rapidly and may contain unequivocal cancer cells with improved morphology  Word of caution!!!! Metastatic carcinoma  (continued) 34
Characteristic features of some specific primary sites   Metastatic carcinoma  (continued) 35
Metastatic adenocarcinoma- NOS ,  (peritoneal fluid).  Cohesive groups of cells in papillary configurations show eccentrically placed nuclei touching the periphery of cells (arrows in b,c,f). The cells in such groups are difficult to study at lower magnification (a,b). However, the cell morphology in such groups can be observed at the periphery, especially under higher magnification (arrow in b). Some groups show gland-like spaces (arrowheads in d,e,f). [a-c: Papanicolaou stained SurePath preparation; d-f: Diff-Quik stained Cytospin preparation. (a, 10X; b, 40X; c, 100XZoomed; d, 10X; e, 40X; f, 100XZoomed)]. 36 Characteristic features of some specific primary sites   a b c d e f
a b c d e f w 2 1 Metastatic poorly differentiated adenocarcinoma of lung,   (pleural fluid). The Diff-Quik stained preparation demonstrates reactive mesothelial cells (arrowhead 1 in a) mixed with a ‘second population’ of cohesive groups of cells (arrow 2 in a) with eccentric nuclei that touch the periphery of the carcinoma cells (arrowheads in b,c,f). Some cells are less cohesive with nearby small groups or solitary carcinoma cells (arrows in d,e,f). Occasional intercellular spaces, resembling mesothelial window, are present (arrowhead w in c). The patient had poorly differentiated adenocarcinoma of lung.  [a-c: Diff-Quik stained Cytospin preparation, d-f: Papanicolaou stained SurePath preparation. (a, 10X; b,c, 100X; d, 10X; e,f, 100X)].  37 Characteristic features of some specific primary sites   (continued)
a c d g h e f i j RM b RM c g j i h d f e Ly NC RM nm nm NC Metastatic small cell carcinoma,   (pleural fluid). Cancer cells (a,b) are present as solitary cells (c,d), small groups (g,h,i), and large groups (b & j). The cells are small with high nucleocytoplasmic ratios (c,d,g,h.i). The nuclei are hyperchromatic with salt and pepper chromatin (c,d,i). Solitary cancer cells (NC) (c,d) resemble lymphocytes (blue arrow Ly in f) and may be misinterpreted as lymphoma, especially in PAP stained preparations. However, the presence of cohesive groups (g,h,i,j) with various patterns, including Indian-file pattern (g), typify carcinoma. The nuclear molding (arrows nm in g & i) distinguishes them from other poorly differentiated carcinomas. Mitotic figures (arrowhead in e) and apoptotic cancer cells (arrowheads in d,f,h) are also present. Rare reactive mesothelial cells (blue arrows RM in a,b,e) are present with a few chronic inflammatory cells (blue arrow Ly in f) in the background. Immunostained cell block sections showed immunoreactivity for neuroendocrine immunomarkers (chromogranin, synaptophysin, and CD56). The patient had poorly differentiated small cell carcinoma of lung.  (NC, neoplastic cell; RM, reactive mesothelial cell, nm, nuclear molding, Ly, lymphocyte) [a-j: Papanicolaou stained SurePath preparation. (a-b, 100X; c-j, 100XZoomed)]. 38 Characteristic features of some specific primary sites   (continued)
a b c d e f g h RM NC NC NC RM TTF-1 Metastatic bronchioloalveolar cell carcinoma of lung ,  (pleural fluid). Cellular specimen (a) shows three dimensional groups of carcinoma cells (arrowheads in a-f) mixed with reactive mesothelial cells (blue arrow RM in f,g). The  two populations  are demonstrated more distinctly with the DQ stain (f,g) than with the PAP stain (a-e). However, the  morphological details  of individual neoplastic cells are superior in the PAP stain (a-e), especially under higher magnification (c-e). The individual cells show features of well differentiated adenocarcinoma (red arrows NC in d,e,g). Although, usually not conspicuous, some of the carcinoma cells have prominent nucleoli (d,e). The neoplastic cells demonstrate nuclear immunoreactivity for TTF-1 (arrowheads in h) consistent with a lung primary. The patient had bronchioloalveolar cell carcinoma of lung.  (NC, neoplastic cell; RM, reactive mesothelial cell; TTF-1 Thyroid transcription factor- 1) [a-e: Papanicolaou stained SurePath preparation; f-g: Diff-Quik stained Cytospin preparation; h: Immunostained cell-block section. (a, 10X; b, 40X; c, 100X; d-e, 100XZoomed; f, 40X; g, 100X; h, 40X)].  39 Characteristic features of some specific primary sites   (continued)
Metastatic mammary carcinoma,  (pleural fluid). a-g:   Proliferation spheres  (red arrows NC) with mostly reactive mesothelial cells (blue arrows RM) and inflammatory cells in the background, clearly separated out in the immunostained cell-block sections (a,e). The reactive mesothelial cells (blue arrows RM) stand out distinctly from the neoplastic cells (red arrow NC) in the DQ stain. However, the reactive mesothelial cells in the PAP stain (blue arrows in g) are difficult to distinguish from neoplastic cells (compare with case in h-j).  h-j:  A different patient with metastatic mammary carcinoma. The effusion predominantly contains solitary adenocarcinoma cells, as highlighted by the BerEP4 immunostained section (red arrows NC in h). The carcinoma cells (red arrows NC in j) can be distinguished easily from reactive mesothelial cells (blue arrow RM in j) in the DQ stain (j), but not in the PAP stain (i). A mitotic figure is present (blue arrow MF in i). Note the resemblance of reactive mesothelial cells in f & g to neoplastic cells in i. Without the help of DQ stain and immunocytochemistry, such fluids, with predominantly one type of cell population, may easily be misinterpreted.   [a,e,h: Immunostained cell-block sections; f,g,i: Papanicolaou (PAP) stained SurePath preparation; b,c,d,,j: Diff-Quik (DQ) stained Cytospin preparation. (a, 40X; b, 100X; c,d, 100XZoomed; e, 40X; f, 100X; g, 100XZoomed; h, 40XZoomed; i, 100X; j, 100XZoomed)]. 40 Characteristic features of some specific primary sites   (continued) Calretinin RM NC BerEP4 RM NC NC BerEP4 NC NC NC RM g i h f e c a j b d MF RM NC RM RM RM RM RM NC RM
Metastatic adenocarcinoma of colon,  (peritoneal fluid). Cohesive groups of cells (a) show high nucleocytoplasmic ratios and eccentric nuclei touching the periphery of the cell (arrow in b). Some adenocarcinoma cells show cytoplasmic vacuoles containing mucin (arrowhead in the inset of b). The cell groups in papillary configurations are difficult to study at lower magnification (c). Peripheral palisading is better observed under higher magnification (d). The patient had colonic adenocarcinoma. [a,b: Diff-Quik (DQ) stained Cytospin preparation, c-d: Papanicolaou (PAP) stained SurePath preparation. (a, 40X; b, 100X; c, 40X; d, 100)].  41 Characteristic features of some specific primary sites   (continued) a b c d
Metastatic gastric adenocarcinoma,  (peritoneal fluid).  The specimen contained a predominance of solitary neoplastic cells (red arrows a,d) with rare reactive mesothelial cells (blue arrow RM in a). Most of the cancer cells have eccentric nuclei touching the periphery of the cells (a,b,c,d). The reactive mesothelial cells (blue arrow RM) are identifiable more easily in the Diff-Quik stained (a) than in the PAP stained (c) preparation. The solitary carcinoma cells may be misinterpreted as high-grade lymphoma cells, especially in PAP stained preparations (c,d). Apoptotic cancer cells (yellow arrow ‘e’ in c) and mitotic figures (yellow arrow ‘f’ in c) are also present.  The predominance of solitary neoplastic cells (a-j) is confirmed in the HE stained (g & h) and BerEP4 (i) immunostained cell-block sections. A few CK 7 immunoreactive mesothelial cells, as intrinsic positive control, are present amongst many neoplastic cells (j). Although, the adenocarcinoma cells in this case were non-immunoreactive for CK 7 (j), a significant proportion of gastric adenocarcinomas are immunoreactive for CK 7. The patient had linitis plastica type diffuse anaplastic gastric adenocarcinoma.  (AP, apoptotic cancer cell; CK 7, cytokeratin 7; MF, mitotic figure; NC, neoplastic cell; RM, reactive mesothelial cell) [a-b: Diff-Quik (DQ) stained Cytospin preparation; c-f: Papanicolaou (PAP) stained SurePath preparation; g,h: HE stained cell-block section; i,j: Immunostained cell-block sections. (a, 100X; b, 100XZoomed; c, 100X; d-f, 100XZoomed; g, 40X; h-j 100X)]. 42 Characteristic features of some specific primary sites   (continued) a c b d g h e f i j RM d f e b BerEP4 CK 7 NC NC AP MF
Metastatic pancreatic adenocarcinoma,  (peritoneal fluid).  The neoplastic cells (NC) are as loosely cohesive groups (a) or as solitary cells (b,e) with eccentric nuclei.  PAP stained preparations facilitate evaluation of cellular details in cohesive groups (c & d).  A few cell groups show gland-like structures (arrow in d). ‘Second population’ (arrows in f,g,&h) of neoplastic cells is highlighted distinctly in immunostained cell-block sections f through h (immunoreactive for BerEP4 in f, non-immunoreactive for vimentin in g and calretinin in h). As inbuilt corresponding positive controls, inflammatory and reactive mesothelial cells (arrowhead in g) are immunoreactive for vimentin and reactive mesothelial cells (arrowhead RM in h) are immunoreactive for calretinin. The patient had pancreatic adenocarcinoma.  (NC, neoplastic cell; RM, reactive mesothelial cell) [a-b: Diff-Quik (DQ) stained Cytospin preparation; c-e: Papanicolaou (PAP) stained SurePath preparation; f-h: Immunostained cell-block sections. (a-e, 100X; f-h, 40X)].  43 Characteristic features of some specific primary sites   (continued) BerEP4 f d e c b a bi bii vimentin NC NC NC NC Calretinin RM g h
Metastatic ovarian serous papillary cystadenocarcinoma,  (peritoneal fluid).  Psammoma bodies (red arrows PSM in a.b,c,e,f,i) are present, isolated and in association with papillary clusters (d,f) of adenocarcinoma cells without stromal cores (g,h). Some carcinoma cells show degenerative vacuoles (blue arrows VAC in h), which should not be misinterpreted as mucinous. Some apoptotic neoplastic cells (blue arrow AP in i) are present. (AP, apoptotic cancer cell; NC, neoplastic cell; PSM, psammoma body; VAC, vacuole) [a-i: Papanicolaou (PAP) stained SurePath preparation. (a, 20X; b, 40X; c-e, 100X, f-i , 100XZoomed)]. 44 Characteristic features of some specific primary sites   (continued) a b c d e f g h i PSM VAC PSM PSM PSM PSM AP PSM VAC NC
Primary peritoneal carcinoma,  (peritoneal fluid). The specimen shows a predominance of groups of adenocarcinoma cells in papillary configurations (a,d) without stromal cores (g). Solitary neoplastic cells (red arrows NC in a,b,d,e) are easily distinguished from the rare reactive mesothelial cells (blue arrowheads RM in a,c,d,e). However, in PAP stained preparation (d), reactive mesothelial cells (arrowhead RM in e) have significant morphological overlap with neoplastic cells (red arrows NC in d & e). Mitotic figures (yellow arrow MF in a) and apoptotic cells (yellow arrows AP in d,f) are present concurrently. Some cells show degenerative vacuolation (a,b). These vacuoles may resemble secretory vacuoles and lead to misinterpretation of mucinous adenocarcinoma. The cancer cells do not show nuclear immunoreactivity for calretinin (h), but they are immunoreactive for BerEP4 (i). The neoplastic cells show nuclear (and cytoplasmic) immunoreactivity for WT-1(j). The patient had ascites with diffuse peritoneal involvement with omental caking. The ovaries were not enlarged.  (AP, apoptotic cancer cell; MF, mitotic figure; NC, neoplastic cell; RM, reactive mesothelial cell) [a-c: Diff-Quik (DQ) stained Cytospin preparation; d-f: Papanicolaou (PAP) stained SurePath preparation; g: HE stained cell-block section; h-j: Immunostained cell-block sections. (a, 100X; b,c, 100XZoomed; d, 100X; e,f, 100XZoomed; h-j, 100X)]. 45 Characteristic features of some specific primary sites   (continued) a d b c g h e f i j WT-1 BerEP4 Calret c b RM NC AP e f RM NC AP MF NC RM NC NC RM NC
a b c d Metastatic ovarian mucinous cystadenocarcinoma,  (peritoneal fluid). Cohesive groups of neoplastic cells with high nucleocytoplasmic ratios and eccentric nuclei touching the periphery of the cells (arrow in b) are present. Some carcinoma cells have cytoplasmic vacuoles (a,b). The cell groups in papillary configurations are difficult to study at lower magnification (c). However, the cell morphology in such groups can be observed at the periphery of the papillation, especially under higher magnification (arrow in d). The patient had ovarian mucinous cystadenocarcinoma. [a,b: Diff-Quik (DQ) stained Cytospin preparation; c,d: Papanicolaou (PAP) stained SurePath preparation. (a, 40X; b, 100X; c, 40X; d, 100X)]. 46 Characteristic features of some specific primary sites   (continued)
Metastatic ovarian adenocarcinoma,  (peritoneal fluid). The neoplastic cells show an  Indian file pattern.  This arrangement is not specific for particular carcinoma (Ref 14); in addition to metastatic mammary carcinoma and small cell carcinoma of lung (see Figure 9.3a,b,g), this pattern may be seen in other non-small cell carcinomas, as in this case with metastatic ovarian adenocarcinoma.  [a: Papanicolaou (PAP) stained SurePath preparation; b: Diff-Quik (DQ) stained Cytospin preparation. (a-b, 100X)]. 47 Characteristic features of some specific primary sites   (continued) a b
Metastatic carcinoma of endometrium,  (pleural fluid). Papillary-like cohesive groups (blue arrow in a) of columnar cells (red arrow in d). The patient had endometrial carcinoma of endometrioid type. [a-d: Papanicolaou (PAP) stained SurePath preparation. (a, 10X; b, 40X; c,d, 100X)]. 48 Characteristic features of some specific primary sites   (continued) a b c d
Metastatic prostatic adenocarcinoma,  (peritoneal fluid).   Cohesive small groups of cancer cells (red arrows in a,e,f,i,j) with mostly eccentric nuclei touching the periphery of the cells are present with some solitary cancer cells (red arrows NC in a,,c,d,f,g,h). Reactive mesothelial cells (blue arrows RM in a,b) are more easily and distinctly identifiable in DQ stained (a) than in PAP stained (f) preparations. Most cancer cells were poorly cohesive, manifested by the presence of small groups (e,i,j) or solitary cells (c,d,g,h). Some cells show vacuolation (f,g,h,i,j) which may be  in vitro  degenerative or functional with secretion. The patient had prostatic adenocarcinoma with colonic metastasis. The primary tumor also showed a few vacuolated cancer cells in tissue sections. (NC, neoplastic cell; RM, reactive mesothelial cell) [a-e: Diff-Quik (DQ) stained Cytospin preparation; f-j: Papanicolaou (PAP) stained SurePath preparation. (a, 100X; b-e, 100XZoomed; f, 100X; g-j, 100XZoomed)].  49 Characteristic features of some specific primary sites   (continued) RM RM RM a f b c d e g h i j RM RM NC  NC  NC  NC  NC  NC
Metastatic papillary carcinoma of thyroid,   (pleural fluid). ‘ Second population’ of cohesive papillary groups (red arrows NC in b,e,f) of cells associated with Psammoma bodies with concentric lamination (red arrow PSM in g2,h2’) are seen amongst a few reactive mesothelial cells (blue arrows RM in b,i).  d1, single tumor cells with eccentric nucleus touching the periphery (blue arrow) DQ stained preparation. d2, single cells may have cytoplasmic vacuole with colloid (arrowhead) in DQ stained preparation. j1, single tumor cells with eccentric nucleus touching the periphery in PAP stained preparation.  j2, compare with reactive mesothelial cell (binucleate) with central nuclei in j1 in PAP stained preparation.  The patient had papillary carcinoma of thyroid.  [NC, neoplastic cell(s); PSM, psammoma body; RM, reactive mesothelial cell(s)] [a-d: Diff-Quik (DQ) stained Cytospin preparation; e-j: Papanicolaou (PAP) stained SurePath preparation. (a, 40X; b,c, 100X; d1,d2, 100XZoomed; e, 10X; f, 40X; g1,g2,h1,h2,i, 100X; j1,j2, 100XZoomed)]. 50 Characteristic features of some specific primary sites   (continued) a b c e g1 f d1 d2 g2 Second focus of ‘h1’  ( bright light) h1 h2 i j1 j2 NC RM NC RM NC NC Second focus of ‘g1’  ( bright light) PSM PSM
Metastatic cholangiocarcinoma,  (peritoneal fluid).  Cancer cells (red arrows in a,h) are present mostly as solitary cells with eccentric nuclei touching the periphery of the cells (b,d,i,k,l) with occasional loosely cohesive groups of cancer cells (a,f) and reactive mesothelial cells (c,e,j and arrowheads in a,h). A few cells show cytoplasmic vacuoles (i) with secretion (yellow arrow in l) which is positive for mucicarmine in cell-block section (n). Some apoptotic cancer cells (yellow arrow AP) are also present (g,m). The morphological features overlap those of other mucinous adenocarcinomas. The patient had cholangiocarcinoma with a mucinous pattern.  (AP, apoptotic cancer cell; NC, neoplastic cell; RM, reactive mesothelial cell) [a-g: Diff-Quik stained Cytospin preparation; h-m: Papanicolaou stained SurePath preparation; n: Mucicarmine stained cell block section. (a, 100X; b-g, 100XZoomed; h, 100X; i-m, 100XZoomed); n, 100XZoomed)].   51 Characteristic features of some specific primary sites   (continued) a b h c d e i k b c d e l k i m g l j f f g m n j AP NC RM NC RM NC RM NC AP
A. Sarcomas I. Blue cell tumors Ia.  Rhabdomyosarcoma ai.   Embryonal rhabdomyosarcoma aii.   Alveolar rhabdomyosarcoma Ib.  Neuroblastoma Ic.  Wilms’ tumor Id.  PNET and Ewing’s sarcoma (EWS) Ie.  Desmoplastic round cell tumor (DSRCT) II. Fibrosarcoma and other sarcomas   B. Malignant Melanoma C. Other malignancies  such as  germ cell tumors Metastatic non-epithelial neoplasms 52
More frequently encountered in  children  than in adults.  The most common causes in children-    ( followed  by  Lymphoma and leukemia )   Non-epithelial neoplasms including-  Wilms’ tumor   Neuroblastoma   Ewing’s sarcoma , and  Embryonal rhab­domyosarcoma   Metastatic non-epithelial neoplasms  (continued) 53
Metastatic non-epithelial neoplasms  (continued) Effusion fluids -   Usually  sparsely cellular Cells-  Single  or in loose clusters Tendency to  round up  due to the surface tension from the surrounding fluid Lack the tissue arrangement  and vascular or stromal pattern Cytoplasm - Indistinct cytoplasmic borders May show  bipolar cytoplasmic processes Nuclei -  Binucleation or multi-nucleation  may be present.  Round ,  oval , and sometimes  fusiform or spindle shaped   Irregular contours , often with  nuclear membrane infolding Chromatin clumping  with  parachromatin clearing Prominent nucleoli 54
Metastatic non-epithelial neoplasms  (continued) Metastatic fibrosarcoma  (peritoneal fluid).   Moderately cellular specimen with predominantly scattered single tumor cells. 55
Metastatic non-epithelial neoplasms  (continued) Metastatic melanoma  (peritoneal fluid).  Dyshesive clusters of malignant cells. ‘Cell-in-cell’ pattern may be present.  56
Metastatic non-epithelial neoplasms  (continued) Desmoplastic small round cell tumor   (DSRCT)   (peritoneal fluid).  Dyshesive clusters of small round tumor cells showing rosette-like features (FNAB). DSRCT effusion exhibiting high cellularity. The tumor cells showed nuclear immunoreactivity for WT1. [ With thanks from the article in ‘open access’ cytopathology journal:   Granja NM et al  CytoJournal  2005, 2:6  Free full text at-   http://www.cytojournal.com/content/pdf/1742-6413-2-6.pdf ] 57
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) Adults : Lymphoma  is the  third most common  cause of a malignant pleural  effusion  after  lung and breast carcinoma . 58 Pleural fluids, largest group (61%); followed by ascitic fluid (26%) and pericardial fluid (7.5%).  Majority from patients with a documented neoplasm (pleural 47.5%, ascitic 23%,, and pericardial 43%)  In sporadic Burkitt lymphoma (80-91% of patients) present with abdominal masses which represent involvement of peritoneum, omentum, bowel mesentery, or bowel wall.  Children:   The most common causes of malignant effusions are  hematopoietic neoplasms .
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) Air-dried Diff-Quik or Wright-Giemsa stained  preparations- Have traditionally been the stains of choice for  hematopoietic cells ,  Especially for examining  subtle cytoplasmic details and variations .  Papanicolaou-stained  preparations-   Allow better examination of nuclear details.  The hematolymphoid cells-are  non-cohesive  in cytological specimens.  Exceptions  can occur- e.g. lymphocytes in  tuberculosis effusions  may  form “ lymphoid aggregates ” Lymphoglandular bodies-   Typically are inconspicuous or absent in effusion smears  59
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],60
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) A.  Follicular lymphoma lymphocyte with characteristic cleaved or notched nucleus. B.  CLL cells in pleural fluid cytospin preparation. C.  Bloody pleural fluid in a patient with CLL.  Contamination  with peripheral blood  must be considered before diagnosing involvement with CLL. Chronic Lymphocytic Leukemia  (pleural fluid)  61
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) Monomorphous population of medium sized Burkitt lymphoma cells with prominent cytoplasmic vacuolization. Note the mitosis in C. Burkitt lymphoma  (peritoneal fluid) A-C. Diff-Quik stain 62
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) Diffuse Large B Cell Lymphoma ,  (ascitic fluid).  Large atypical lymphoid cells (A-D).  E. Histology section from primary colonic DLBCL of same patient. A-B. Diff-Quik stain, C-D. Pap-stain, E. HE stained section of primary colonic DLBCL. 63
Hematolymphoid disorders (Lymphomas and leukemias)  (continued) HHV-8 associated lymphoma cells in ascitic fluid. Primary effusion lymphoma,  (ascitic fluid). A,B. Wright-Giemsa stain 64
Thank you Milwaukee Art Museum [email_address] End Diagnostic Cytopathology of  Serous Effusions  II

More Related Content

What's hot

Cell block and its diagnostic utility
Cell block and its diagnostic utilityCell block and its diagnostic utility
Cell block and its diagnostic utility
Gaurav Gupta
 
papillary lesions of the breast.pptx
papillary lesions of the breast.pptxpapillary lesions of the breast.pptx
papillary lesions of the breast.pptx
SirnaEmana1
 
Eosinophils in lymph node
Eosinophils in lymph nodeEosinophils in lymph node
Eosinophils in lymph node
Monika Nema
 
cytology of body fluid
 cytology of body fluid cytology of body fluid
cytology of body fluidMusa Khan
 
Gross of thyroid gland
Gross of thyroid glandGross of thyroid gland
Gross of thyroid gland
Monika Nema
 
Giant cell lesions of bone
Giant cell lesions of boneGiant cell lesions of bone
Giant cell lesions of bone
Shreya D Prabhu
 
Urine.cytology
Urine.cytologyUrine.cytology
Urine.cytology
Pranveer Rao
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
BPS GMC (W) KHANPUR KALAN SONEPAT
 
Cytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesionsCytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesions
Aseem Jain
 
Effusion cytology - Diagnosis.
Effusion cytology - Diagnosis.Effusion cytology - Diagnosis.
Effusion cytology - Diagnosis.
namrathrs87
 
introduction of cytopathology
introduction of cytopathologyintroduction of cytopathology
introduction of cytopathology
Appy Akshay Agarwal
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
dhanya89
 
Milan cytology reporting
Milan cytology reportingMilan cytology reporting
Milan cytology reporting
Argha Baruah
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
Dr Niharika Singh
 
Grossing of breast
Grossing of breastGrossing of breast
Grossing of breast
SmritiSingh171
 
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminarImmunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Pannaga Kumar
 
Cytology of bone lesions
Cytology of bone lesionsCytology of bone lesions
Salivary gland-- cytology .pptx
Salivary gland-- cytology .pptxSalivary gland-- cytology .pptx
Salivary gland-- cytology .pptx
KalaivaniGanapathy
 
Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretation Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretation
Spoorthy Gurajala
 
Cell block and liquid based cytology
Cell block and liquid based cytologyCell block and liquid based cytology
Cell block and liquid based cytologyDr Neha Mahajan
 

What's hot (20)

Cell block and its diagnostic utility
Cell block and its diagnostic utilityCell block and its diagnostic utility
Cell block and its diagnostic utility
 
papillary lesions of the breast.pptx
papillary lesions of the breast.pptxpapillary lesions of the breast.pptx
papillary lesions of the breast.pptx
 
Eosinophils in lymph node
Eosinophils in lymph nodeEosinophils in lymph node
Eosinophils in lymph node
 
cytology of body fluid
 cytology of body fluid cytology of body fluid
cytology of body fluid
 
Gross of thyroid gland
Gross of thyroid glandGross of thyroid gland
Gross of thyroid gland
 
Giant cell lesions of bone
Giant cell lesions of boneGiant cell lesions of bone
Giant cell lesions of bone
 
Urine.cytology
Urine.cytologyUrine.cytology
Urine.cytology
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
 
Cytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesionsCytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesions
 
Effusion cytology - Diagnosis.
Effusion cytology - Diagnosis.Effusion cytology - Diagnosis.
Effusion cytology - Diagnosis.
 
introduction of cytopathology
introduction of cytopathologyintroduction of cytopathology
introduction of cytopathology
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
 
Milan cytology reporting
Milan cytology reportingMilan cytology reporting
Milan cytology reporting
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
 
Grossing of breast
Grossing of breastGrossing of breast
Grossing of breast
 
Immunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminarImmunohistochemistry in diagnosis of soft tissue tumours seminar
Immunohistochemistry in diagnosis of soft tissue tumours seminar
 
Cytology of bone lesions
Cytology of bone lesionsCytology of bone lesions
Cytology of bone lesions
 
Salivary gland-- cytology .pptx
Salivary gland-- cytology .pptxSalivary gland-- cytology .pptx
Salivary gland-- cytology .pptx
 
Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretation Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretation
 
Cell block and liquid based cytology
Cell block and liquid based cytologyCell block and liquid based cytology
Cell block and liquid based cytology
 

Similar to 02 Presentations Ii Vs (14 4 Mb) (3 30 08)

04 Presentations IV VS (8MB)- (3-28-08) .pps
04 Presentations IV VS (8MB)- (3-28-08) .pps04 Presentations IV VS (8MB)- (3-28-08) .pps
04 Presentations IV VS (8MB)- (3-28-08) .pps
vshidham
 
Diagnostic-Cytology_23.04.2020.pptx
Diagnostic-Cytology_23.04.2020.pptxDiagnostic-Cytology_23.04.2020.pptx
Diagnostic-Cytology_23.04.2020.pptx
Pravin Amabade
 
ACUTE LEUKAEMIA Anika.ppt
ACUTE LEUKAEMIA Anika.pptACUTE LEUKAEMIA Anika.ppt
ACUTE LEUKAEMIA Anika.ppt
AngaiAnika
 
TB System ReportingThyroid Cytopathology
TB System ReportingThyroid CytopathologyTB System ReportingThyroid Cytopathology
TB System ReportingThyroid Cytopathology
aamanimutakani
 
PMU third/fourth year Clinical pathoanatomy Part 2
PMU third/fourth year Clinical pathoanatomy Part 2PMU third/fourth year Clinical pathoanatomy Part 2
PMU third/fourth year Clinical pathoanatomy Part 2
BenjiH
 
Presentation dr rahul seminar (2)[1387]
Presentation dr rahul  seminar (2)[1387]Presentation dr rahul  seminar (2)[1387]
Presentation dr rahul seminar (2)[1387]
rahulraj956
 
discuss the CLASSIFICATION OF KIDNEY TUMOURS.pptx
discuss the CLASSIFICATION OF KIDNEY TUMOURS.pptxdiscuss the CLASSIFICATION OF KIDNEY TUMOURS.pptx
discuss the CLASSIFICATION OF KIDNEY TUMOURS.pptx
Harunausman10
 
CSF Examination
CSF ExaminationCSF Examination
CSF Examination
Gaurav S
 
6. stem cells+regeneration dr ashutosh kumar
6. stem cells+regeneration dr ashutosh kumar6. stem cells+regeneration dr ashutosh kumar
6. stem cells+regeneration dr ashutosh kumarDrAshutosh Kumar
 
Salivary gland tumors
Salivary gland tumorsSalivary gland tumors
Salivary gland tumors
K BHATTACHARJEE
 
Leukopoiesis formation of white blood cell
Leukopoiesis formation of white blood cellLeukopoiesis formation of white blood cell
Leukopoiesis formation of white blood cell
Rubab161509
 
Journal article review
Journal article reviewJournal article review
Journal article review
Sansar Babu Tiwari
 
Leukemia
Leukemia Leukemia
Leukemia
Aparna A
 
Management Of Malignant Salivary Gland Tumors- Okoye
Management Of Malignant Salivary Gland Tumors- OkoyeManagement Of Malignant Salivary Gland Tumors- Okoye
Management Of Malignant Salivary Gland Tumors- Okoye
Chukwuma-Ikem Okoye
 
Management Of Benign Salivary Gland Tumors - Okoye
Management Of Benign Salivary Gland Tumors - OkoyeManagement Of Benign Salivary Gland Tumors - Okoye
Management Of Benign Salivary Gland Tumors - Okoye
Chukwuma-Ikem Okoye
 
paris presentation.pptx
paris presentation.pptxparis presentation.pptx
paris presentation.pptx
KarishmaBhuyan
 
03 Presentations III VS (8-47MB)- (3-28-08).pps
03 Presentations III VS (8-47MB)- (3-28-08).pps03 Presentations III VS (8-47MB)- (3-28-08).pps
03 Presentations III VS (8-47MB)- (3-28-08).pps
vshidham
 
csf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncturecsf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncture
LincyJohny1
 
bethesda system of thyroid cytopathology.pptx
bethesda system of thyroid cytopathology.pptxbethesda system of thyroid cytopathology.pptx
bethesda system of thyroid cytopathology.pptx
anweshaagarwal1
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamid
ayeshahmed786
 

Similar to 02 Presentations Ii Vs (14 4 Mb) (3 30 08) (20)

04 Presentations IV VS (8MB)- (3-28-08) .pps
04 Presentations IV VS (8MB)- (3-28-08) .pps04 Presentations IV VS (8MB)- (3-28-08) .pps
04 Presentations IV VS (8MB)- (3-28-08) .pps
 
Diagnostic-Cytology_23.04.2020.pptx
Diagnostic-Cytology_23.04.2020.pptxDiagnostic-Cytology_23.04.2020.pptx
Diagnostic-Cytology_23.04.2020.pptx
 
ACUTE LEUKAEMIA Anika.ppt
ACUTE LEUKAEMIA Anika.pptACUTE LEUKAEMIA Anika.ppt
ACUTE LEUKAEMIA Anika.ppt
 
TB System ReportingThyroid Cytopathology
TB System ReportingThyroid CytopathologyTB System ReportingThyroid Cytopathology
TB System ReportingThyroid Cytopathology
 
PMU third/fourth year Clinical pathoanatomy Part 2
PMU third/fourth year Clinical pathoanatomy Part 2PMU third/fourth year Clinical pathoanatomy Part 2
PMU third/fourth year Clinical pathoanatomy Part 2
 
Presentation dr rahul seminar (2)[1387]
Presentation dr rahul  seminar (2)[1387]Presentation dr rahul  seminar (2)[1387]
Presentation dr rahul seminar (2)[1387]
 
discuss the CLASSIFICATION OF KIDNEY TUMOURS.pptx
discuss the CLASSIFICATION OF KIDNEY TUMOURS.pptxdiscuss the CLASSIFICATION OF KIDNEY TUMOURS.pptx
discuss the CLASSIFICATION OF KIDNEY TUMOURS.pptx
 
CSF Examination
CSF ExaminationCSF Examination
CSF Examination
 
6. stem cells+regeneration dr ashutosh kumar
6. stem cells+regeneration dr ashutosh kumar6. stem cells+regeneration dr ashutosh kumar
6. stem cells+regeneration dr ashutosh kumar
 
Salivary gland tumors
Salivary gland tumorsSalivary gland tumors
Salivary gland tumors
 
Leukopoiesis formation of white blood cell
Leukopoiesis formation of white blood cellLeukopoiesis formation of white blood cell
Leukopoiesis formation of white blood cell
 
Journal article review
Journal article reviewJournal article review
Journal article review
 
Leukemia
Leukemia Leukemia
Leukemia
 
Management Of Malignant Salivary Gland Tumors- Okoye
Management Of Malignant Salivary Gland Tumors- OkoyeManagement Of Malignant Salivary Gland Tumors- Okoye
Management Of Malignant Salivary Gland Tumors- Okoye
 
Management Of Benign Salivary Gland Tumors - Okoye
Management Of Benign Salivary Gland Tumors - OkoyeManagement Of Benign Salivary Gland Tumors - Okoye
Management Of Benign Salivary Gland Tumors - Okoye
 
paris presentation.pptx
paris presentation.pptxparis presentation.pptx
paris presentation.pptx
 
03 Presentations III VS (8-47MB)- (3-28-08).pps
03 Presentations III VS (8-47MB)- (3-28-08).pps03 Presentations III VS (8-47MB)- (3-28-08).pps
03 Presentations III VS (8-47MB)- (3-28-08).pps
 
csf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncturecsf.pptx found in spinal cord. Csf is collected by lambar puncture
csf.pptx found in spinal cord. Csf is collected by lambar puncture
 
bethesda system of thyroid cytopathology.pptx
bethesda system of thyroid cytopathology.pptxbethesda system of thyroid cytopathology.pptx
bethesda system of thyroid cytopathology.pptx
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamid
 

More from vshidham

Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...
Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...
Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...
vshidham
 
Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...
Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...
Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...
vshidham
 
Ser fl cytol ico pune jan 7, 2012 (handout)
Ser fl cytol ico  pune jan 7, 2012 (handout)Ser fl cytol ico  pune jan 7, 2012 (handout)
Ser fl cytol ico pune jan 7, 2012 (handout)
vshidham
 
Vshidham how to write article 9-25-2011
Vshidham  how to write article 9-25-2011Vshidham  how to write article 9-25-2011
Vshidham how to write article 9-25-2011
vshidham
 
Shidham's protocol for cell block preparation
Shidham's protocol for cell block preparationShidham's protocol for cell block preparation
Shidham's protocol for cell block preparation
vshidham
 
Shidham- Immunohistochemistry in Serous Fluid Cytopathology
Shidham- Immunohistochemistry in  Serous Fluid CytopathologyShidham- Immunohistochemistry in  Serous Fluid Cytopathology
Shidham- Immunohistochemistry in Serous Fluid Cytopathology
vshidham
 
Overview of FNA procedure- S. K. Navale Medical College, Pune, India
Overview of FNA procedure- S. K. Navale Medical College, Pune, IndiaOverview of FNA procedure- S. K. Navale Medical College, Pune, India
Overview of FNA procedure- S. K. Navale Medical College, Pune, India
vshidham
 
Dr Shidham brief bio-sketch-2010
Dr Shidham  brief bio-sketch-2010Dr Shidham  brief bio-sketch-2010
Dr Shidham brief bio-sketch-2010
vshidham
 
Teaching Pathology To Medical Students 10 25 09
Teaching Pathology To Medical Students 10 25 09Teaching Pathology To Medical Students 10 25 09
Teaching Pathology To Medical Students 10 25 09
vshidham
 
CytoJournal- Open Access & CMAS on EUS FNA of Pancreas
CytoJournal- Open Access & CMAS on EUS FNA of PancreasCytoJournal- Open Access & CMAS on EUS FNA of Pancreas
CytoJournal- Open Access & CMAS on EUS FNA of Pancreas
vshidham
 
Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...
Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...
Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...
vshidham
 
Potpouri Of Asc H Shidham Et Al (Wk#13 Asc Annual Meeting 2008)
Potpouri Of Asc H  Shidham Et Al (Wk#13 Asc Annual Meeting 2008)Potpouri Of Asc H  Shidham Et Al (Wk#13 Asc Annual Meeting 2008)
Potpouri Of Asc H Shidham Et Al (Wk#13 Asc Annual Meeting 2008)
vshidham
 
03 Asc H Medicolegal Austin
03 Asc H  Medicolegal  Austin03 Asc H  Medicolegal  Austin
03 Asc H Medicolegal Austin
vshidham
 
02 Asc H Continued Chivkula
02 Asc H Continued  Chivkula02 Asc H Continued  Chivkula
02 Asc H Continued Chivkula
vshidham
 
01 Potpouri Of Asc H Shidham
01 Potpouri Of Asc H  Shidham01 Potpouri Of Asc H  Shidham
01 Potpouri Of Asc H Shidham
vshidham
 
00 Potpouri Of Asc H
00 Potpouri Of Asc H00 Potpouri Of Asc H
00 Potpouri Of Asc H
vshidham
 

More from vshidham (16)

Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...
Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...
Handout for Round table #19 at American Society of Cytopathology (Nov 9, 2013...
 
Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...
Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...
Round table #19 at American Society of Cytopathology (Nov 5, 2012, Las Vegas,...
 
Ser fl cytol ico pune jan 7, 2012 (handout)
Ser fl cytol ico  pune jan 7, 2012 (handout)Ser fl cytol ico  pune jan 7, 2012 (handout)
Ser fl cytol ico pune jan 7, 2012 (handout)
 
Vshidham how to write article 9-25-2011
Vshidham  how to write article 9-25-2011Vshidham  how to write article 9-25-2011
Vshidham how to write article 9-25-2011
 
Shidham's protocol for cell block preparation
Shidham's protocol for cell block preparationShidham's protocol for cell block preparation
Shidham's protocol for cell block preparation
 
Shidham- Immunohistochemistry in Serous Fluid Cytopathology
Shidham- Immunohistochemistry in  Serous Fluid CytopathologyShidham- Immunohistochemistry in  Serous Fluid Cytopathology
Shidham- Immunohistochemistry in Serous Fluid Cytopathology
 
Overview of FNA procedure- S. K. Navale Medical College, Pune, India
Overview of FNA procedure- S. K. Navale Medical College, Pune, IndiaOverview of FNA procedure- S. K. Navale Medical College, Pune, India
Overview of FNA procedure- S. K. Navale Medical College, Pune, India
 
Dr Shidham brief bio-sketch-2010
Dr Shidham  brief bio-sketch-2010Dr Shidham  brief bio-sketch-2010
Dr Shidham brief bio-sketch-2010
 
Teaching Pathology To Medical Students 10 25 09
Teaching Pathology To Medical Students 10 25 09Teaching Pathology To Medical Students 10 25 09
Teaching Pathology To Medical Students 10 25 09
 
CytoJournal- Open Access & CMAS on EUS FNA of Pancreas
CytoJournal- Open Access & CMAS on EUS FNA of PancreasCytoJournal- Open Access & CMAS on EUS FNA of Pancreas
CytoJournal- Open Access & CMAS on EUS FNA of Pancreas
 
Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...
Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...
Recent Advances in Pathologic Evaluation of Melanoma Sentinel Lymph Nodes. Sl...
 
Potpouri Of Asc H Shidham Et Al (Wk#13 Asc Annual Meeting 2008)
Potpouri Of Asc H  Shidham Et Al (Wk#13 Asc Annual Meeting 2008)Potpouri Of Asc H  Shidham Et Al (Wk#13 Asc Annual Meeting 2008)
Potpouri Of Asc H Shidham Et Al (Wk#13 Asc Annual Meeting 2008)
 
03 Asc H Medicolegal Austin
03 Asc H  Medicolegal  Austin03 Asc H  Medicolegal  Austin
03 Asc H Medicolegal Austin
 
02 Asc H Continued Chivkula
02 Asc H Continued  Chivkula02 Asc H Continued  Chivkula
02 Asc H Continued Chivkula
 
01 Potpouri Of Asc H Shidham
01 Potpouri Of Asc H  Shidham01 Potpouri Of Asc H  Shidham
01 Potpouri Of Asc H Shidham
 
00 Potpouri Of Asc H
00 Potpouri Of Asc H00 Potpouri Of Asc H
00 Potpouri Of Asc H
 

Recently uploaded

Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Thierry Lestable
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
RTTS
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
CatarinaPereira64715
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Product School
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
DanBrown980551
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
Product School
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
Product School
 
Search and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical FuturesSearch and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical Futures
Bhaskar Mitra
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Product School
 
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
Abida Shariff
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
Cheryl Hung
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance
 

Recently uploaded (20)

Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
 
ODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User GroupODC, Data Fabric and Architecture User Group
ODC, Data Fabric and Architecture User Group
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
 
Search and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical FuturesSearch and Society: Reimagining Information Access for Radical Futures
Search and Society: Reimagining Information Access for Radical Futures
 
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
 
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
 

02 Presentations Ii Vs (14 4 Mb) (3 30 08)

  • 1. 1 Diagnostic Cytopathology of Serous Effusions Session II ( 8.45-9.30 ) To view this session on web copy-paste the following URL into your browser: http://www.slideshare.net/vshidham/02-presentations-ii-vs-14-4-mb-3-30-08 Vinod B. Shidham , MD, FRCPath, FIAC Professor Executive editor & coeditor-in-chief, CytoJournal ( www.cytojournal.com ) Department of Pathology Medical College of Wisconsin 9200 W Wisconsin Av, Milwaukee, WI 53226, USA [email_address] 2008 Wisconsin Society of Cytology SPRING MEETING, 40TH ANNIVERSARY Holiday Inn – Riverwalk, Neenah, WI Saturday, April 19, 2008 (7.30 to 3.30)
  • 2. 2 Outline Session I (40 minutes): Anatomy, histology, cytology, and effusions Collection, transportation, and processing of effusion fluids Factors leading to potential diagnostic pitfalls Approach to diagnostic cytopathology of effusions The panorama of different face of mesothelial cells Session II (45 minutes): Benign conditions with/without specific cellular patterns Mesothelioma Metastatic carcinoma Metastatic sarcoma and melanoma Hematolymphoid disorders (Lymphomas and leukemias) Session III (45 minutes): Evaluation of unknown primary sites of origin- Where do they come from? Immunocytochemistry of effusion fluids: SCIP (Subtractive Coordinate Immunoreactivity Pattern) approach Flow cytometry, molecular techniques, and other special techniques Session IV (45 minutes): Diagnostic cytopathology of peritoneal washings Diagnostic pitfalls in cytopathology of serous cavity fluids Study cases
  • 3. 2 Outline Session I (40 minutes): Anatomy, histology, cytology, and effusions Collection, transportation, and processing Factors leading to potential diagnostic pitfalls Approach to diagnostic cytopathology of effusions The panorama of different face of mesothelial cells Session II (45 minutes): Benign conditions with/without specific cellular patterns Mesothelioma Metastatic carcinoma Metastatic sarcoma and melanoma Hematolymphoid disorders (Lymphomas and leukemias) Session III (45 minutes): Evaluation of unknown primary sites of origin- Where do they come from? Immunocytochemistry of effusion fluids: SCIP (Subtractive Coordinate Immunoreactivity Pattern) approach Flow cytometry, molecular techniques, and other special techniques Session IV (45 minutes): Diagnostic cytopathology of peritoneal washings Diagnostic pitfalls in cytopathology of serous cavity fluids Study cases
  • 4. In adults most of the pleural, peritoneal, and pericardial effusions are related to benign conditions like: Congestive heart failure Cirrhosis of the liver Pericarditis. 3
  • 5. 4 Benign conditions with/without specific cellular patterns Session II May mimic carcinoma Extremely reactive mesothelial cells may exhibit atypia overlapping with malignancy Diagnose of malignancy with extreme caution. Immunophenotyping with SCIP approach objectively decide nature of atypical cells. Liver Cirrhosis with activity Uremia Acute Pancreatitis Pulmonary embolism and Infarction With characteristic features Systemic Lupus Erythematosus ( SLE) Rheumatoid Effusions Other less common causes of reactive effusions Fistulous tract associated effusions Endometriosis Asbestos exposure associated effusions Talc associated effusions.
  • 6. Mesothelial cells vs adenocarcinoma cells Benign conditions with/without specific cellular patterns (continued) 5 Cytologic Features Mesothelial Cells Adenocarcinoma Cell Types Single cell population (spectrum of mesothelial cells) Second population (mesothelial cells and nonmesothelial-noninflammatory cells) Borders of cell groups Hobnail with cytoplasmic Intercellular windows- Present Smooth community borders of nuclei Intercellular windows- May be present Cell in cell pattern Present Rare Vauolated cells (Signet ring appearance) Absence of mucin in cells Nuclear borders not distorted “ Mucin droplet” present Vacuole distorts cell nucleus Cytoplasm Ecto- and endoplasm Usually homogenous-random Cytoplasmic Blebs Present Absent Immunohistochemistry Mesothelial markers- Positive Epithelial markers- Positive Microvilli (EM) Long, slender, bushy Short, stubby, sparse
  • 7. Benign conditions with/without specific cellular patterns (continued) Reactive mesothelial cells in clusters (ascitic fluid). Mixed with chronic inflammatory cells within the groups and between the mesothelial cells in the background. [Papanicolaou stained ThinPrep preparation (100x Zoomed)]. 6
  • 8. Benign conditions with/without specific cellular patterns (continued) Reactive mesothelial cells in clusters mixed with chronic inflammatory cells, mostly mature lymphocytes (ascitic fluid). This consult case was initially misinterpreted as positive for malignant cells. Extensive search for primary was negative. [Papanicolaou stained ThinPrep preparation (100x Zoomed)]. 7
  • 9. Benign conditions with/without specific cellular patterns (continued) a b c RM-b RM-c F2 F1 F2 F1 Degenerative vacuoles in reactive mesothelial cells (ascitic fluid). 8
  • 10. Benign conditions with/without specific cellular patterns (continued) A thin rim between nuclear border and cell border (1) is seen in mesothelial cells. In comparison, the nuclear border touches the cell border of adenoca cells without a significant cytoplasmic rim (2). [Papanicolaou stained SurePath TM Preparation (b,c,e,f, 100XZoomed)]. Mesothelial cells (a,b,&c) versus adenocarcinoma cells (d,e,&f) with eccentric nuclei . 9 2 2 2 f e d Adenocarcinoma 1 1 1 a c b Mesothelial
  • 11. 10 Peritoneal: Lymphocytic Peritoneal Effusions Cirrhosis Tuberculosis Eosinophilic Peritoneal Effusions Neutrophilic Peritoneal Effusions Spontaneous bacterial peritonitis Extramedullary hematopoiesis / chronic idiopathic myelofibrosis Benign conditions with/without specific cellular patterns (continued) Reactive inflammatory cells in effusion fluids Pleural: Reactive lymphocytic pleural effusions Tuberculosis Eosinophilic Pleural Effusions Neutrophilic Pleural Effusions Pulmonary embolism Parapneumonic effusions Histiocytic Pleural Effusions Rheumatoid arthritis Nodular histiocytic hyperplasia Pericardial Lymphocytic Pericardial effusions Viral pericarditis Eosinophilic Pericardial Effusions Neutrophilic Pericardial Effusions Infectious pericarditis Systemic lupus erythematosus
  • 12. Benign conditions with/without specific cellular patterns (continued) Session II Most frequently exudative Usually pleural , less frequently pericardial . Cytology: Predominance of inflammatory cells (neutrophils, rarely eosinophils or lymphocytes). Most characteristic features is the presence of LE cells - Inflammatory cells (usually a neutrophil, but could be a macrophage) Containing a homogenous hematoxylin body . The number of LE cells noted in effusion sample can vary. Characteristic but not pathognomonic , other conditions including drug (e.g. procainamide, hydralazine, and isoniazid) associated with an SLE-like syndrome may show LE cells. Not consistent association. Systemic Lupus Erythematosus (SLE) 11
  • 13. Benign conditions with/without specific cellular patterns (continued) Session II Systemic Lupus Erythematosus (SLE) LE cells 12 Pleural effusion , Diff Quik stain, 40X Pleural effusion , Papanicolaou stain, 40X
  • 14. Benign conditions with/without specific cellular patterns (continued) Session II Rheumatoid effusions Uncommon but known complication of rheumatoid arthritis. May be concurrent , or occur prior to manifestations of joint disease. Eexudative, more frequently in males than females. Fluids have reduced glucose levels. Cytology Characteristic: Many degenerated cells , necrotic debris , atypical spindled cells resembling spindled squamous cells, histiocytes , and round multinucleated giant cells with many lymphoplasmacytic cells . Mesothelial cells- absent or may be rare. Presence of necrosis in an effusion specimen is almost characteristic for a rheumatoid nodule. Spindled cells with varying degrees of degeneration and frequent pyknosis, may raise the differential diagnosis with squamous cell carcinoma . Non-specific: The characteristic features- not consistent. May only show general reactive pattern - increased neutrophils, lymphocytes and mononuclear cells with reactive mesothelial cells. 13
  • 15. Benign conditions with/without specific cellular patterns (continued) Session II Rheumatoid effusions Lung nodule and pleural effusion. Multinucleated giant cells with many chronic inflammatory cells. Degenerating as well necrotic cells characteristic of rheumatoid effusion are in the background. (Papanicolaou stain, 40X) 14
  • 16. Cells in effusion fluid Mesothelial cells Neoplastic- ♦ Quantity- Many cells ♦ Quality- Many large groups Mesothelioma Non-mesothelial cells Reactive- Usually single cells without large 3-D groups Hematopoietic cells (Non-cohesive cells) Neoplastic - (2nd foreign population) ¶ Carcinoma (Cohesive cells) Sarcoma (Spindle cells may be present. Known history of sarcoma is usually crucial for proper interpretation) Melanoma (Non-cohesive cells) Neoplastic- Lymphoma Reactive- Inflammatory cells ¶ Metastatic cancer cells may be the predominant cells without being seen as a ‘second population’. They may be present as scattered solitary cells with cytomorphology overlapping with floridly reactive mesothelial cells. If indicated, i mmunocytochemistry would facilitate confirmation of these cells as non-mesothelial. 1 3 2 4 7 6 5 6b 6a 8 Algorithm for evaluation of a ‘second foreign population’ . 15
  • 17. Mesothelioma Diagnostic problems in cytological interpretation Cytological features of mesothelioma Rare variants- Clear cell Deciduoid Lymphohistiocytoid Signet-ring cell Small cell Special stains in mesothelioma 16
  • 18. Mesothelioma (continued) Significant overlap between benign and malignant mesothelial cells, and between mesothelioma and adenocarcinoma cells. Important clues are quantitative and qualitative Quantity- Hypercellular specimns with numerous mesothelial cells Ouality- Large groups of three dimensional mesothelial cells Most of these features are evaluated better on Romanowski stained preparations. Diagnostic problems Large aggregates of reactive mesothelial cells- may be misinterpreted with false positive diagnoses. 17
  • 19. Mesothelioma (continued) A single malignant mesothelial cell population Multinucleation Articulation between mesothelial cells (intercellular windows) Cell-in-cell arrangements Cytoplasmic vacuoles Peripheral blebs Cluster of atypical cells with knobby outlines (scalloped borders) Variable nuclear enlargement with prominent nucleoli Cytoplasmic metachromasia Cytological features of mesothelioma 18
  • 20. Mesothelioma (continued) Atypical mitoses may be seen rarely. Background extracellular stromal hyaluronic acid - Metachromatic appearance on Romanowski stains and Fluffy pale green/blue appearance on the Papanicolaou stain . Cytological features of mesothelioma Mesothelial cells (both reactive and neoplastic)- Distinct two-zone appearance with an inner dense ring fading into an outer, delicate, lacy area. Distinguishes mesothelial from adenocarcinoma cells , with diffuse pale cytoplasm with random pattern . General cytological nuclear features of malignancy apply to mesothelioma- Irregular, pleomorphic and enlarged nuclei, prominent nucleoli (including macronucleoli), bi- and multinucleation. However, the features are somewhat subtle and need to be carefully searched. 19
  • 21. Mesothelioma (continued) Mesothelioma - clusters of cells with irregular, knobby outlines- sometimes resemble papillary architecture . Acinar formation (a feature of adenocarcinoma ) rare in mesotheliomas . Intercellular windows may appear like acini.. Cell engulfment (cell-in-cell) is a common in mesotheliomas . Benign effusions- relatively less cellular, with smaller cell groups, mostly two-dimensional. The individual cells may show variable atypia. Adenocarcinoma cell groups- three-dimensional, complex, with a smooth contour (the so-called “ community border ” ). Cytological features of mesothelioma Spindle cells rarely exfoliate in effusion fluids- they may appear polyhedral owing to the surface tension phenomenon . Scattered atypical spindle cells - suspicious for mesothelioma . 20
  • 22. Mesothelioma (continued) Cytological features of mesothelioma Mesothelial cell with two zone cytoplasm (white arrow) and fuzzy microvilli (black arrow). Autocyte Prep. Pap stain 40x. 21
  • 23. Mesothelioma (continued) Cytological features of mesothelioma Loosely cohesive three-dimensional groups of mesothelioma cells with knobby outline. A multinucleate atypical mesothelial cell is seen at the periphery of the group (arrow). Thinprep. Pap stain 40x. 22
  • 24. Mesothelioma (continued) Cytological features of mesothelioma Mesothelial cell with prominent microvilli (white arrow). Autocyte Prep. Pap stain. 60x. 23
  • 25. Mesothelioma (continued) Cytological features of mesothelioma Malignant epithelioid mesothelioma (pleural fluid). Mesothelioma cells show numerous large three dimensional groups of cells. The individual mesothelioma cells hardly show any variation from reactive mesothelial cells without remarkable features of malignancy. The mesothelioma cells like reactive mesothelial cells show two zone staining (red arrow 1) with peripheral vacuolation (blue arrow 2). [a-h, Papanicolaou stained ThinPrep preparation (a,b, 20X; c, 100X; d-h, 100XZoomed)]. 24 1 2 a b c e f g h d
  • 26. Mesothelioma (continued) Cytological features of mesothelioma Cell block from a case of mesothelioma showing hypercellular atypical mesothelial cell groups. Extracellular mucinous material is present in the background (white arrow). H&E. 40X. 25
  • 27. Mesothelioma (continued) Cytological features of mesothelioma Loosely cohesive small group of spindled mesothelial cells in a case of biphasic mesothelioma. Arrow marks an atypical spindled nucleus. Autocyte Prep. Pap stain. 40x. 26
  • 28. Mesothelioma (continued) Peritoneal fluid, Deciduoid mesothelioma . Dyscohesive scattered single atypical enlarged cells Pap stain 10X. [Courtesy Dr. Bernard Naylor]. Cytological features of mesothelioma 27
  • 29. Mesothelioma (continued) Peritoneal fluid, Deciduoid mesothelioma. Enlarged malignant cells with a binucleate form, and glassy cytoplasm. Nuclei are vesicular with prominent nucleoli. Scattered smaller atypical mesothelial cells are present in the background. Pap stain 40X [Courtesy Dr. Bernard Naylor]. Cytological features of mesothelioma 28
  • 30. Mesothelioma (continued) Special stains in mesothelioma Mesothelial cells produce hyaluronic acid - an acidic mucin. Also seen in the background of effusion smears. Adenocarcinoma cells produce neutral mucin . Mesotheliomas- positive for acidic mucin stains such as Alcian Blue . The staining disappears with hyaluronidase pre-digestion . Adenocarcinomas- epithelial (neutral) mucin- Positive with mucicarmine and PAS (diastase resistant)- PAS positive glycogen in mesothelial cells is hydrolyzed by diastase digestion . A positive stain for an epithelial mucin- is useful for a diagnosis of adenocarcinoma, but a negative result does not exclude it. 29
  • 31. Cells in effusion fluid Mesothelial cells Neoplastic- ♦ Quantity- Many cells ♦ Quality- Many large groups Mesothelioma Non-mesothelial cells Reactive- Usually single cells without large 3-D groups Hematopoietic cells (Non-cohesive cells) Neoplastic - (2nd foreign population) ¶ Carcinoma (Cohesive cells) Sarcoma (Spindle cells may be present. Known history of sarcoma is usually crucial for proper interpretation) Melanoma (Non-cohesive cells) Neoplastic- Lymphoma Reactive- Inflammatory cells ¶ Metastatic cancer cells may be the predominant cells without being seen as a ‘second population’. They may be present as scattered solitary cells with cytomorphology overlapping with floridly reactive mesothelial cells. If indicated, i mmunocytochemistry would facilitate confirmation of these cells as non-mesothelial. 1 3 2 4 7 6 5 6b 6a 8 Algorithm for evaluation of a ‘second foreign population’ . 30
  • 32. Metastatic carcinoma Common sources of primary neoplasms causing malignant effusions. Any neoplasm, including rare examples of central nervous system tumor, may involve serous cavity and manifest as malignant effusion. Metastatic adenocarcinoma is, by far, the most common cause of malignant effusions. 31
  • 33. Metastatic carcinoma (continued) Clinical details may be important for cytologic interpretation of effusions. However, depending on the clinical scenario and cytological picture, the clinical history may be misleading, especially with beginners. Some effusions may develop without any history of cancer and may present a diagnostic challenge. Clinical history 32
  • 34. Clinical history (continued) The clinical history can play a critical role in ensuring proper triaging and processing of effusion specimens; therefore, to facilitate appropriate processing of effusions, the clinical history should be provided in all the requisitions. This could avoid suboptimal cytopathologic interpretations. Metastatic carcinoma (continued) 33
  • 35. If the initial findings are equivocal for cancer cells, it is prudent to be extra-cautious by recommending repeat cytologic evaluation on a new specimen. If the initial effusion is caused by cancer, it usually re-accumulates rapidly and may contain unequivocal cancer cells with improved morphology Word of caution!!!! Metastatic carcinoma (continued) 34
  • 36. Characteristic features of some specific primary sites Metastatic carcinoma (continued) 35
  • 37. Metastatic adenocarcinoma- NOS , (peritoneal fluid). Cohesive groups of cells in papillary configurations show eccentrically placed nuclei touching the periphery of cells (arrows in b,c,f). The cells in such groups are difficult to study at lower magnification (a,b). However, the cell morphology in such groups can be observed at the periphery, especially under higher magnification (arrow in b). Some groups show gland-like spaces (arrowheads in d,e,f). [a-c: Papanicolaou stained SurePath preparation; d-f: Diff-Quik stained Cytospin preparation. (a, 10X; b, 40X; c, 100XZoomed; d, 10X; e, 40X; f, 100XZoomed)]. 36 Characteristic features of some specific primary sites a b c d e f
  • 38. a b c d e f w 2 1 Metastatic poorly differentiated adenocarcinoma of lung, (pleural fluid). The Diff-Quik stained preparation demonstrates reactive mesothelial cells (arrowhead 1 in a) mixed with a ‘second population’ of cohesive groups of cells (arrow 2 in a) with eccentric nuclei that touch the periphery of the carcinoma cells (arrowheads in b,c,f). Some cells are less cohesive with nearby small groups or solitary carcinoma cells (arrows in d,e,f). Occasional intercellular spaces, resembling mesothelial window, are present (arrowhead w in c). The patient had poorly differentiated adenocarcinoma of lung. [a-c: Diff-Quik stained Cytospin preparation, d-f: Papanicolaou stained SurePath preparation. (a, 10X; b,c, 100X; d, 10X; e,f, 100X)]. 37 Characteristic features of some specific primary sites (continued)
  • 39. a c d g h e f i j RM b RM c g j i h d f e Ly NC RM nm nm NC Metastatic small cell carcinoma, (pleural fluid). Cancer cells (a,b) are present as solitary cells (c,d), small groups (g,h,i), and large groups (b & j). The cells are small with high nucleocytoplasmic ratios (c,d,g,h.i). The nuclei are hyperchromatic with salt and pepper chromatin (c,d,i). Solitary cancer cells (NC) (c,d) resemble lymphocytes (blue arrow Ly in f) and may be misinterpreted as lymphoma, especially in PAP stained preparations. However, the presence of cohesive groups (g,h,i,j) with various patterns, including Indian-file pattern (g), typify carcinoma. The nuclear molding (arrows nm in g & i) distinguishes them from other poorly differentiated carcinomas. Mitotic figures (arrowhead in e) and apoptotic cancer cells (arrowheads in d,f,h) are also present. Rare reactive mesothelial cells (blue arrows RM in a,b,e) are present with a few chronic inflammatory cells (blue arrow Ly in f) in the background. Immunostained cell block sections showed immunoreactivity for neuroendocrine immunomarkers (chromogranin, synaptophysin, and CD56). The patient had poorly differentiated small cell carcinoma of lung. (NC, neoplastic cell; RM, reactive mesothelial cell, nm, nuclear molding, Ly, lymphocyte) [a-j: Papanicolaou stained SurePath preparation. (a-b, 100X; c-j, 100XZoomed)]. 38 Characteristic features of some specific primary sites (continued)
  • 40. a b c d e f g h RM NC NC NC RM TTF-1 Metastatic bronchioloalveolar cell carcinoma of lung , (pleural fluid). Cellular specimen (a) shows three dimensional groups of carcinoma cells (arrowheads in a-f) mixed with reactive mesothelial cells (blue arrow RM in f,g). The two populations are demonstrated more distinctly with the DQ stain (f,g) than with the PAP stain (a-e). However, the morphological details of individual neoplastic cells are superior in the PAP stain (a-e), especially under higher magnification (c-e). The individual cells show features of well differentiated adenocarcinoma (red arrows NC in d,e,g). Although, usually not conspicuous, some of the carcinoma cells have prominent nucleoli (d,e). The neoplastic cells demonstrate nuclear immunoreactivity for TTF-1 (arrowheads in h) consistent with a lung primary. The patient had bronchioloalveolar cell carcinoma of lung. (NC, neoplastic cell; RM, reactive mesothelial cell; TTF-1 Thyroid transcription factor- 1) [a-e: Papanicolaou stained SurePath preparation; f-g: Diff-Quik stained Cytospin preparation; h: Immunostained cell-block section. (a, 10X; b, 40X; c, 100X; d-e, 100XZoomed; f, 40X; g, 100X; h, 40X)]. 39 Characteristic features of some specific primary sites (continued)
  • 41. Metastatic mammary carcinoma, (pleural fluid). a-g: Proliferation spheres (red arrows NC) with mostly reactive mesothelial cells (blue arrows RM) and inflammatory cells in the background, clearly separated out in the immunostained cell-block sections (a,e). The reactive mesothelial cells (blue arrows RM) stand out distinctly from the neoplastic cells (red arrow NC) in the DQ stain. However, the reactive mesothelial cells in the PAP stain (blue arrows in g) are difficult to distinguish from neoplastic cells (compare with case in h-j). h-j: A different patient with metastatic mammary carcinoma. The effusion predominantly contains solitary adenocarcinoma cells, as highlighted by the BerEP4 immunostained section (red arrows NC in h). The carcinoma cells (red arrows NC in j) can be distinguished easily from reactive mesothelial cells (blue arrow RM in j) in the DQ stain (j), but not in the PAP stain (i). A mitotic figure is present (blue arrow MF in i). Note the resemblance of reactive mesothelial cells in f & g to neoplastic cells in i. Without the help of DQ stain and immunocytochemistry, such fluids, with predominantly one type of cell population, may easily be misinterpreted. [a,e,h: Immunostained cell-block sections; f,g,i: Papanicolaou (PAP) stained SurePath preparation; b,c,d,,j: Diff-Quik (DQ) stained Cytospin preparation. (a, 40X; b, 100X; c,d, 100XZoomed; e, 40X; f, 100X; g, 100XZoomed; h, 40XZoomed; i, 100X; j, 100XZoomed)]. 40 Characteristic features of some specific primary sites (continued) Calretinin RM NC BerEP4 RM NC NC BerEP4 NC NC NC RM g i h f e c a j b d MF RM NC RM RM RM RM RM NC RM
  • 42. Metastatic adenocarcinoma of colon, (peritoneal fluid). Cohesive groups of cells (a) show high nucleocytoplasmic ratios and eccentric nuclei touching the periphery of the cell (arrow in b). Some adenocarcinoma cells show cytoplasmic vacuoles containing mucin (arrowhead in the inset of b). The cell groups in papillary configurations are difficult to study at lower magnification (c). Peripheral palisading is better observed under higher magnification (d). The patient had colonic adenocarcinoma. [a,b: Diff-Quik (DQ) stained Cytospin preparation, c-d: Papanicolaou (PAP) stained SurePath preparation. (a, 40X; b, 100X; c, 40X; d, 100)]. 41 Characteristic features of some specific primary sites (continued) a b c d
  • 43. Metastatic gastric adenocarcinoma, (peritoneal fluid). The specimen contained a predominance of solitary neoplastic cells (red arrows a,d) with rare reactive mesothelial cells (blue arrow RM in a). Most of the cancer cells have eccentric nuclei touching the periphery of the cells (a,b,c,d). The reactive mesothelial cells (blue arrow RM) are identifiable more easily in the Diff-Quik stained (a) than in the PAP stained (c) preparation. The solitary carcinoma cells may be misinterpreted as high-grade lymphoma cells, especially in PAP stained preparations (c,d). Apoptotic cancer cells (yellow arrow ‘e’ in c) and mitotic figures (yellow arrow ‘f’ in c) are also present. The predominance of solitary neoplastic cells (a-j) is confirmed in the HE stained (g & h) and BerEP4 (i) immunostained cell-block sections. A few CK 7 immunoreactive mesothelial cells, as intrinsic positive control, are present amongst many neoplastic cells (j). Although, the adenocarcinoma cells in this case were non-immunoreactive for CK 7 (j), a significant proportion of gastric adenocarcinomas are immunoreactive for CK 7. The patient had linitis plastica type diffuse anaplastic gastric adenocarcinoma. (AP, apoptotic cancer cell; CK 7, cytokeratin 7; MF, mitotic figure; NC, neoplastic cell; RM, reactive mesothelial cell) [a-b: Diff-Quik (DQ) stained Cytospin preparation; c-f: Papanicolaou (PAP) stained SurePath preparation; g,h: HE stained cell-block section; i,j: Immunostained cell-block sections. (a, 100X; b, 100XZoomed; c, 100X; d-f, 100XZoomed; g, 40X; h-j 100X)]. 42 Characteristic features of some specific primary sites (continued) a c b d g h e f i j RM d f e b BerEP4 CK 7 NC NC AP MF
  • 44. Metastatic pancreatic adenocarcinoma, (peritoneal fluid). The neoplastic cells (NC) are as loosely cohesive groups (a) or as solitary cells (b,e) with eccentric nuclei. PAP stained preparations facilitate evaluation of cellular details in cohesive groups (c & d). A few cell groups show gland-like structures (arrow in d). ‘Second population’ (arrows in f,g,&h) of neoplastic cells is highlighted distinctly in immunostained cell-block sections f through h (immunoreactive for BerEP4 in f, non-immunoreactive for vimentin in g and calretinin in h). As inbuilt corresponding positive controls, inflammatory and reactive mesothelial cells (arrowhead in g) are immunoreactive for vimentin and reactive mesothelial cells (arrowhead RM in h) are immunoreactive for calretinin. The patient had pancreatic adenocarcinoma. (NC, neoplastic cell; RM, reactive mesothelial cell) [a-b: Diff-Quik (DQ) stained Cytospin preparation; c-e: Papanicolaou (PAP) stained SurePath preparation; f-h: Immunostained cell-block sections. (a-e, 100X; f-h, 40X)]. 43 Characteristic features of some specific primary sites (continued) BerEP4 f d e c b a bi bii vimentin NC NC NC NC Calretinin RM g h
  • 45. Metastatic ovarian serous papillary cystadenocarcinoma, (peritoneal fluid). Psammoma bodies (red arrows PSM in a.b,c,e,f,i) are present, isolated and in association with papillary clusters (d,f) of adenocarcinoma cells without stromal cores (g,h). Some carcinoma cells show degenerative vacuoles (blue arrows VAC in h), which should not be misinterpreted as mucinous. Some apoptotic neoplastic cells (blue arrow AP in i) are present. (AP, apoptotic cancer cell; NC, neoplastic cell; PSM, psammoma body; VAC, vacuole) [a-i: Papanicolaou (PAP) stained SurePath preparation. (a, 20X; b, 40X; c-e, 100X, f-i , 100XZoomed)]. 44 Characteristic features of some specific primary sites (continued) a b c d e f g h i PSM VAC PSM PSM PSM PSM AP PSM VAC NC
  • 46. Primary peritoneal carcinoma, (peritoneal fluid). The specimen shows a predominance of groups of adenocarcinoma cells in papillary configurations (a,d) without stromal cores (g). Solitary neoplastic cells (red arrows NC in a,b,d,e) are easily distinguished from the rare reactive mesothelial cells (blue arrowheads RM in a,c,d,e). However, in PAP stained preparation (d), reactive mesothelial cells (arrowhead RM in e) have significant morphological overlap with neoplastic cells (red arrows NC in d & e). Mitotic figures (yellow arrow MF in a) and apoptotic cells (yellow arrows AP in d,f) are present concurrently. Some cells show degenerative vacuolation (a,b). These vacuoles may resemble secretory vacuoles and lead to misinterpretation of mucinous adenocarcinoma. The cancer cells do not show nuclear immunoreactivity for calretinin (h), but they are immunoreactive for BerEP4 (i). The neoplastic cells show nuclear (and cytoplasmic) immunoreactivity for WT-1(j). The patient had ascites with diffuse peritoneal involvement with omental caking. The ovaries were not enlarged. (AP, apoptotic cancer cell; MF, mitotic figure; NC, neoplastic cell; RM, reactive mesothelial cell) [a-c: Diff-Quik (DQ) stained Cytospin preparation; d-f: Papanicolaou (PAP) stained SurePath preparation; g: HE stained cell-block section; h-j: Immunostained cell-block sections. (a, 100X; b,c, 100XZoomed; d, 100X; e,f, 100XZoomed; h-j, 100X)]. 45 Characteristic features of some specific primary sites (continued) a d b c g h e f i j WT-1 BerEP4 Calret c b RM NC AP e f RM NC AP MF NC RM NC NC RM NC
  • 47. a b c d Metastatic ovarian mucinous cystadenocarcinoma, (peritoneal fluid). Cohesive groups of neoplastic cells with high nucleocytoplasmic ratios and eccentric nuclei touching the periphery of the cells (arrow in b) are present. Some carcinoma cells have cytoplasmic vacuoles (a,b). The cell groups in papillary configurations are difficult to study at lower magnification (c). However, the cell morphology in such groups can be observed at the periphery of the papillation, especially under higher magnification (arrow in d). The patient had ovarian mucinous cystadenocarcinoma. [a,b: Diff-Quik (DQ) stained Cytospin preparation; c,d: Papanicolaou (PAP) stained SurePath preparation. (a, 40X; b, 100X; c, 40X; d, 100X)]. 46 Characteristic features of some specific primary sites (continued)
  • 48. Metastatic ovarian adenocarcinoma, (peritoneal fluid). The neoplastic cells show an Indian file pattern. This arrangement is not specific for particular carcinoma (Ref 14); in addition to metastatic mammary carcinoma and small cell carcinoma of lung (see Figure 9.3a,b,g), this pattern may be seen in other non-small cell carcinomas, as in this case with metastatic ovarian adenocarcinoma. [a: Papanicolaou (PAP) stained SurePath preparation; b: Diff-Quik (DQ) stained Cytospin preparation. (a-b, 100X)]. 47 Characteristic features of some specific primary sites (continued) a b
  • 49. Metastatic carcinoma of endometrium, (pleural fluid). Papillary-like cohesive groups (blue arrow in a) of columnar cells (red arrow in d). The patient had endometrial carcinoma of endometrioid type. [a-d: Papanicolaou (PAP) stained SurePath preparation. (a, 10X; b, 40X; c,d, 100X)]. 48 Characteristic features of some specific primary sites (continued) a b c d
  • 50. Metastatic prostatic adenocarcinoma, (peritoneal fluid). Cohesive small groups of cancer cells (red arrows in a,e,f,i,j) with mostly eccentric nuclei touching the periphery of the cells are present with some solitary cancer cells (red arrows NC in a,,c,d,f,g,h). Reactive mesothelial cells (blue arrows RM in a,b) are more easily and distinctly identifiable in DQ stained (a) than in PAP stained (f) preparations. Most cancer cells were poorly cohesive, manifested by the presence of small groups (e,i,j) or solitary cells (c,d,g,h). Some cells show vacuolation (f,g,h,i,j) which may be in vitro degenerative or functional with secretion. The patient had prostatic adenocarcinoma with colonic metastasis. The primary tumor also showed a few vacuolated cancer cells in tissue sections. (NC, neoplastic cell; RM, reactive mesothelial cell) [a-e: Diff-Quik (DQ) stained Cytospin preparation; f-j: Papanicolaou (PAP) stained SurePath preparation. (a, 100X; b-e, 100XZoomed; f, 100X; g-j, 100XZoomed)]. 49 Characteristic features of some specific primary sites (continued) RM RM RM a f b c d e g h i j RM RM NC NC NC NC NC NC
  • 51. Metastatic papillary carcinoma of thyroid, (pleural fluid). ‘ Second population’ of cohesive papillary groups (red arrows NC in b,e,f) of cells associated with Psammoma bodies with concentric lamination (red arrow PSM in g2,h2’) are seen amongst a few reactive mesothelial cells (blue arrows RM in b,i). d1, single tumor cells with eccentric nucleus touching the periphery (blue arrow) DQ stained preparation. d2, single cells may have cytoplasmic vacuole with colloid (arrowhead) in DQ stained preparation. j1, single tumor cells with eccentric nucleus touching the periphery in PAP stained preparation. j2, compare with reactive mesothelial cell (binucleate) with central nuclei in j1 in PAP stained preparation. The patient had papillary carcinoma of thyroid. [NC, neoplastic cell(s); PSM, psammoma body; RM, reactive mesothelial cell(s)] [a-d: Diff-Quik (DQ) stained Cytospin preparation; e-j: Papanicolaou (PAP) stained SurePath preparation. (a, 40X; b,c, 100X; d1,d2, 100XZoomed; e, 10X; f, 40X; g1,g2,h1,h2,i, 100X; j1,j2, 100XZoomed)]. 50 Characteristic features of some specific primary sites (continued) a b c e g1 f d1 d2 g2 Second focus of ‘h1’ ( bright light) h1 h2 i j1 j2 NC RM NC RM NC NC Second focus of ‘g1’ ( bright light) PSM PSM
  • 52. Metastatic cholangiocarcinoma, (peritoneal fluid). Cancer cells (red arrows in a,h) are present mostly as solitary cells with eccentric nuclei touching the periphery of the cells (b,d,i,k,l) with occasional loosely cohesive groups of cancer cells (a,f) and reactive mesothelial cells (c,e,j and arrowheads in a,h). A few cells show cytoplasmic vacuoles (i) with secretion (yellow arrow in l) which is positive for mucicarmine in cell-block section (n). Some apoptotic cancer cells (yellow arrow AP) are also present (g,m). The morphological features overlap those of other mucinous adenocarcinomas. The patient had cholangiocarcinoma with a mucinous pattern. (AP, apoptotic cancer cell; NC, neoplastic cell; RM, reactive mesothelial cell) [a-g: Diff-Quik stained Cytospin preparation; h-m: Papanicolaou stained SurePath preparation; n: Mucicarmine stained cell block section. (a, 100X; b-g, 100XZoomed; h, 100X; i-m, 100XZoomed); n, 100XZoomed)]. 51 Characteristic features of some specific primary sites (continued) a b h c d e i k b c d e l k i m g l j f f g m n j AP NC RM NC RM NC RM NC AP
  • 53. A. Sarcomas I. Blue cell tumors Ia. Rhabdomyosarcoma ai. Embryonal rhabdomyosarcoma aii. Alveolar rhabdomyosarcoma Ib. Neuroblastoma Ic. Wilms’ tumor Id. PNET and Ewing’s sarcoma (EWS) Ie. Desmoplastic round cell tumor (DSRCT) II. Fibrosarcoma and other sarcomas B. Malignant Melanoma C. Other malignancies such as germ cell tumors Metastatic non-epithelial neoplasms 52
  • 54. More frequently encountered in children than in adults. The most common causes in children- ( followed by Lymphoma and leukemia ) Non-epithelial neoplasms including- Wilms’ tumor Neuroblastoma Ewing’s sarcoma , and Embryonal rhab­domyosarcoma Metastatic non-epithelial neoplasms (continued) 53
  • 55. Metastatic non-epithelial neoplasms (continued) Effusion fluids - Usually sparsely cellular Cells- Single or in loose clusters Tendency to round up due to the surface tension from the surrounding fluid Lack the tissue arrangement and vascular or stromal pattern Cytoplasm - Indistinct cytoplasmic borders May show bipolar cytoplasmic processes Nuclei - Binucleation or multi-nucleation may be present. Round , oval , and sometimes fusiform or spindle shaped Irregular contours , often with nuclear membrane infolding Chromatin clumping with parachromatin clearing Prominent nucleoli 54
  • 56. Metastatic non-epithelial neoplasms (continued) Metastatic fibrosarcoma (peritoneal fluid). Moderately cellular specimen with predominantly scattered single tumor cells. 55
  • 57. Metastatic non-epithelial neoplasms (continued) Metastatic melanoma (peritoneal fluid). Dyshesive clusters of malignant cells. ‘Cell-in-cell’ pattern may be present. 56
  • 58. Metastatic non-epithelial neoplasms (continued) Desmoplastic small round cell tumor (DSRCT) (peritoneal fluid). Dyshesive clusters of small round tumor cells showing rosette-like features (FNAB). DSRCT effusion exhibiting high cellularity. The tumor cells showed nuclear immunoreactivity for WT1. [ With thanks from the article in ‘open access’ cytopathology journal: Granja NM et al CytoJournal 2005, 2:6 Free full text at- http://www.cytojournal.com/content/pdf/1742-6413-2-6.pdf ] 57
  • 59. Hematolymphoid disorders (Lymphomas and leukemias) (continued) Adults : Lymphoma is the third most common cause of a malignant pleural effusion after lung and breast carcinoma . 58 Pleural fluids, largest group (61%); followed by ascitic fluid (26%) and pericardial fluid (7.5%). Majority from patients with a documented neoplasm (pleural 47.5%, ascitic 23%,, and pericardial 43%) In sporadic Burkitt lymphoma (80-91% of patients) present with abdominal masses which represent involvement of peritoneum, omentum, bowel mesentery, or bowel wall. Children: The most common causes of malignant effusions are hematopoietic neoplasms .
  • 60. Hematolymphoid disorders (Lymphomas and leukemias) (continued) Air-dried Diff-Quik or Wright-Giemsa stained preparations- Have traditionally been the stains of choice for hematopoietic cells , Especially for examining subtle cytoplasmic details and variations . Papanicolaou-stained preparations- Allow better examination of nuclear details. The hematolymphoid cells-are non-cohesive in cytological specimens. Exceptions can occur- e.g. lymphocytes in tuberculosis effusions may form “ lymphoid aggregates ” Lymphoglandular bodies- Typically are inconspicuous or absent in effusion smears 59
  • 61.
  • 62. Hematolymphoid disorders (Lymphomas and leukemias) (continued) A. Follicular lymphoma lymphocyte with characteristic cleaved or notched nucleus. B. CLL cells in pleural fluid cytospin preparation. C. Bloody pleural fluid in a patient with CLL. Contamination with peripheral blood must be considered before diagnosing involvement with CLL. Chronic Lymphocytic Leukemia (pleural fluid) 61
  • 63. Hematolymphoid disorders (Lymphomas and leukemias) (continued) Monomorphous population of medium sized Burkitt lymphoma cells with prominent cytoplasmic vacuolization. Note the mitosis in C. Burkitt lymphoma (peritoneal fluid) A-C. Diff-Quik stain 62
  • 64. Hematolymphoid disorders (Lymphomas and leukemias) (continued) Diffuse Large B Cell Lymphoma , (ascitic fluid). Large atypical lymphoid cells (A-D). E. Histology section from primary colonic DLBCL of same patient. A-B. Diff-Quik stain, C-D. Pap-stain, E. HE stained section of primary colonic DLBCL. 63
  • 65. Hematolymphoid disorders (Lymphomas and leukemias) (continued) HHV-8 associated lymphoma cells in ascitic fluid. Primary effusion lymphoma, (ascitic fluid). A,B. Wright-Giemsa stain 64
  • 66. Thank you Milwaukee Art Museum [email_address] End Diagnostic Cytopathology of Serous Effusions II